Author:
Shi Jia-Cheng,Chen Xiao-Huan,Yang Qiong,Wang Cai-Mei,Huang Qian,Shen Yan-Ming,Yu Jian
Abstract
AbstractCurrently, the most widely used screening methods for hyperuricemia (HUA) involves invasive laboratory tests, which are lacking in many rural hospitals in China. This study explored the use of non-invasive physical examinations to construct a simple prediction model for HUA, in order to reduce the economic burden and invasive operations such as blood sampling, and provide some help for the health management of people in poor areas with backward medical resources. Data of 9252 adults from April to June 2017 in the Affiliated Hospital of Guilin Medical College were collected and divided randomly into a training set (n = 6364) and a validation set (n = 2888) at a ratio of 7:3. In the training set, non-invasive physical examination indicators of age, gender, body mass index (BMI) and prevalence of hypertension were included for logistic regression analysis, and a nomogram model was established. The classification and regression tree (CART) algorithm of the decision tree model was used to build a classification tree model. Receiver operating characteristic (ROC) curve, calibration curve and decision curve analyses (DCA) were used to test the distinction, accuracy and clinical applicability of the two models. The results showed age, gender, BMI and prevalence of hypertension were all related to the occurrence of HUA. The area under the ROC curve (AUC) of the nomogram model was 0.806 and 0.791 in training set and validation set, respectively. The AUC of the classification tree model was 0.802 and 0.794 in the two sets, respectively, but were not statistically different. The calibration curves and DCAs of the two models performed well on accuracy and clinical practicality, which suggested these models may be suitable to predict HUA for rural setting.
Funder
Guilin Scientific Research and Technology Development Project
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Salem, C. B., Slim, R., Fathallah, N. & Hmouda, H. Drug-induced hyperuricaemia and gout. Rheumatology 56(5), 679–688 (2017).
2. Schlee, S., Bollheimer, L. C., Bertsch, T., Sieber, C. C. & Härle, P. Crystal arthritides—Gout and calcium pyrophosphate arthritis : part 2: clinical features, diagnosis and differential diagnostics. Z Gerontol Geriatr 51(5), 579–584 (2018).
3. Liu, Y., Yan, L., Lu, J., Wang, J. & Ma, H. A pilot study on the epidemiology of hyperuricemia in Chinese adult population based on big data from Electronic Medical Records 2014 to 2018. Minerva Endocrinol 45, 97–105 (2020).
4. Stewart, D. J., Langlois, V. & Noone, D. Hyperuricemia and hypertension: Links and risks. Integr Blood Press Control 12, 43–62 (2019).
5. Arersa, K. K., Wondimnew, T., Welde, M. & Husen, T. M. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients attending Jimma Medical Center, Southwestern Ethiopia, 2019. Diabetes Metab Syndr Obes 13, 2059–2067 (2020).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献